Drug Ther Bull. 1999 Jun;37(6):47-8. doi: 10.1136/dtb.1999.37647.
Retinoids have been given systemically for severe psoriasis for several years. Tazarotene (Zorac-Allergan), the first retinoid to be marketed as a topical preparation for psoriasis, was recently licensed for mild-to-moderate plaque psoriasis involving up to 10% of the body surface area. Here we assess its place in the management of psoriasis.
